Literature DB >> 29703224

Factors associated with amputation among patients with diabetic foot ulcers in a Saudi population.

Imad R Musa1, Mohanned O N Ahmed2, Elsanousi Ibrahim Sabir1, Ibrahim F Alsheneber1, Elsayed M E Ibrahim1, Gussay Badawi Mohamed1, Rasha Elamin Awadallah1, Tarig Abbas3, Gasim Ibrahim Gasim4.   

Abstract

OBJECTIVES: A prospective study was conducted at the Armed Forces Hospital, Dhahran, Saudi Arabia, between January 2015 and December 2016 to identify the risk factors associated with amputation among diabetic foot ulcers DFUs patients.
RESULTS: In total, 82 patients were recruited. Fifty-five of the patients were males (67.07%), the mean (SD) age of the participants was 60 (± 11.4) years, the mean duration of diabetes was 8.5 (± 3.7) years, and the mean haemoglobin A1c was 4.8 (± 2.8)%. In Univariate analysis, older age and high white blood cell count (WBC) were factors associated with amputation (OR = 1.1, 95% CI = 1-1.1, P = 0.012; and OR = 383, 95% CI = 7.9-18,665, P = 0.003, respectively). On the other hand, an ischaemic ulcer was half as likely as a neuropathic ulcer to lead to amputation (OR = 0.5, 95% CI = 0.3-0.9, P = 0.036), and a higher Wagner's grade was found to be protective against amputation OR = 14.5, 95% CI = 4.3-49.4, P < 0.001. In conclusion, the current study showed that although a number of factors have been described to complicate diabetic ulcers by different researchers, none of those factors were identified in our study apart from older age and high WBC.

Entities:  

Keywords:  Amputation; Complications; Diabetic foot ulcers; Saudi Arabia

Mesh:

Year:  2018        PMID: 29703224      PMCID: PMC5921536          DOI: 10.1186/s13104-018-3372-z

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Introduction

Diabetes mellitus is a common endocrinopathy known for its various complications, including diabetic foot ulcers (DFUs) which often result in amputated limbs [1]. The prevalence of foot ulcers among patients with diabetes mellitus ranges from 4 to 10%, and its lifetime incidence may reach up to 25% [2]. Conservative management of DFU may be affected by proper offloading of the wounds, correct daily foot hygiene, and impaired distal vascular flow. Treatment of a DFU is difficult; it frequently gets infected, and it is therefore a very common cause of hospitalization [3]. Diabetes mellitus increases the risk of lower extremity amputations (LEAs) by up to 56% over 5 years, and the bulk of these amputations are reported to be predated (up to 85%) by a poorly healing ulcer [4]. It is predicted that diabetes-related LEAs will remain a significant source of morbidity and mortality, taking into consideration the rapid global growth of the diabetic population and the high incidence of DFUs [5]. The Global Lower Extremity Study Group defines LEA as the complete loss of any part of the lower limb regardless of the cause [6]. Nearly 82% of LEAs occur among diabetics suffering foot ulceration [7]. The track to ulceration and finally LEA may include essential contributions from background diabetes-related pathophysiology (neuropathy, peripheral arterial disease (PAD), foot deformity and impaired joint mobility), initiating environments (trauma), infection, and complicated healing [8]. The indications for LEA are varied and include severe soft-tissue infection, osteomyelitis, the presence of peripheral arterial occlusion, and gangrene. The impact of LEA surgery on an individual patient is substantial, and therefore amputation is always the last resort for any unsalvageable limb [9]. Regardless of its cause, the avoidance of amputation should be attempted once a DFU has developed or been identified in the hospital [4, 5]. DFUs follow a common progression, starting with a small ulcer or a surgical wound. The bulk of DFUs (60–80%) heal, while 10–15% of them continue to be active, and up to 24% of DFUs eventually lead to LEAs [4, 8]. Previous research has shown that the duration of diabetes mellitus [10], a history of previous amputations or foot ulceration [11], inadequate glycaemic control [12], a history of hypertension [13], hyperlipidaemia [13], the presence of PAD [13], a history of peripheral neuropathy [14], a history of osteomyelitis [15], and wound severity [16] are independent risk factors for LEA. Furthermore, old age [17], a history of smoking [18], anaemia [19], an elevated white blood cell count [20], hypoalbuminemia [19], and the presence of microvascular [15, 21] and macrovascular complications [22, 23] are all believed to contribute to these risk factors. Nevertheless, different studies have reported different findings, and the published data identifying such predictors for diabetes-related LEA in Saudi Arabia are scarce. Considering the previous facts about DFUs along with their great burden in Saudi Arabia, where its prevalence ranges from 11.4 to 29.7% [24, 25]. The current study was conducted to identify the factors associated with amputation among patients with DFU in a Saudi population.

Main text

Methods

A prospective study was conducted to collect data from patients presenting with diabetic foot ulcers to King Abdul Aziz Armed Forces Hospital in Dhahran City, Saudi Arabia, between January 2015 and December 2016, where they were treated and followed based on a standardized protocol until the wound healed or the patient died. Patients who underwent revascularization were excluded. All lesions were evaluated by the same team to minimize assessment discrepancies. After obtaining the written informed consent of the patients, the data were collected using a standardized, pretested questionnaire that included demographic data (age, gender, marital status, residence, and education level), history of smoking, history of alcohol consumption, duration of diabetes, The outcome of the DFU(whether the patient was amputated or not) haematological and biochemical profile at the first admission (complete blood count, blood glucose, haemoglobin A1c level, lipid profile, kidney profile, and Wagner’s grade). For operational purposes, a diabetic foot ulcer was defined as a breach of the normal skin manifesting as an induration, ulceration or change in foot colour lasting for 2 weeks or more in a known diabetes mellitus patient (DM) or an individual recently diagnosed with DM. Amputation was documented if it resulted from surgery, spontaneously or both in a patient with DFU.

Ethical approval

Ethical approval for the study was obtained from the ethical committee at the Armed Forces Hospital at King Abdulaziz Air Base in Al Dhahran.

Statistical analysis

After data entry, the SPSS (version 20) statistical package was used for data analysis. After checking for the normality of the distribution of the data, non-normally distributed data were log-transformed, and then the means and standard deviations were calculated. Univariate analysis was performed to identify factors associated with amputation in patients with DFUs. The P value was considered significant if it was less than 0.05.

Results

In total, 82 patients were recruited. Fifty-five of the patients were male (67.07%), and the mean (SD) age of the participants was 60 (11.4) years. The mean duration of diabetes was 8.5 (3.7) years. These patients showed a mean haemoglobin A1c of 4.8 (2.8)%. Thirty-three patients (40.24%) underwent amputation by the end of the study. Among this group of patients who underwent amputation, 2 were Wagner’s grade 1, 14 were Wagner’s grade 2, 11 were Wagner’s 3, and the remaining 6 were grade 4 when they started the study; none of the ulcers were Wagner’s grade 5 (Table 1). Univariate analysis showed that older age and high WBC were factors associated with amputation (OR = 1.1, 95% CI = 1–1.1, P = 0.012; and OR = 383, 95% CI = 7.9–18,665, P = 0.003, respectively). On the other hand, an ischaemic ulcer was half as likely as a neuropathic ulcer to lead to amputation (OR = 0.5, 95% CI = 0.3–0.9, P = 0.036), and a higher Wagner’s grade was found to be protective against amputation OR = 14.5, 95% CI = 4.3–49.4, P < 0.001 (Table 2).
Table 1

The characteristics of the study population

VariableNot amputatedAmputated
Gender (number of patients)
 Male3124
 Female189
Age, mean (SD) (years)60.0 (11.4)66 (12.6)
Duration of diabetes, mean (SD) (years)8.5 (3.6)6.8 (4)
Haemoglobin A1c, mean (SD)4.8 (2.8)3.8 (2.8)
Triglycerides, mean (SD)1.7 (1.9)1.8 (1.7)
Cholesterol, mean (SD)3.8 (1.3)4.2 (1.1)
Haemoglobin, mean (SD)12.6 (1.2)10 (2.3)
Total white blood cell count, mean (SD) (cells/cm2) × 10310 (0.0015)12.6 (0.0016)
Type of ulcer (number of patients)
 Ischaemic218
 Neuropathic1113
 Mixed1712
Other comorbidities1811
History of hypertension3921
History of smoking46
Wagner’s grade
 Grade 192
 Grade 21414
 Grade 31111
 Grade 4126
 Grade 520
Table 2

Univariate analysis of the predictors of diabetic foot ulcer outcome among a Saudi population

VariableORCIP value
Gender (number of patients)
 Male0.30.1–1.10.076
 Female
Age, mean (SD) (years)1.11–1.10.012
Duration of diabetes, mean (SD) (years)0.70.3–1.70.402
Haemoglobin A1c, mean (SD)0.60.2–1.80.318
Triglycerides, mean (SD)1.30.1–24.70.859
Cholesterol, mean (SD)1.30.7–2.60.388
Haemoglobin, mean (SD)0.0040.0–1.90.076
Total white blood cell count, mean (SD) (cells/cm2) × 1033837.9–18,6650.003
Type of ulcer (number of patients)
 Ischaemic
 Neuropathic0.50.3–0.90.036
 Mixed
Other comorbidities0.30.1–0.90.026
History of hypertension0.50.1–1.70.249
History of smoking1.20.2–6.20.833
Wagner’s grade
 Grade 1
 Grade 2
 Grade 314.54.3–49.4< 0.001
 Grade 4
 Grade 5
The characteristics of the study population Univariate analysis of the predictors of diabetic foot ulcer outcome among a Saudi population

Discussion

Published data about diabetic ulcers in Saudi Arabia is scarce, and the current report is one of the few studies discussing this important issue. The mean age of the study participants was 60 (± 11.4) years, which is a younger age than in the study by Altawfiq et al., where the mean age was 64.8 years [26]. The probable explanation for this is the worldwide metabolic syndrome epidemic, which is particularly affecting the Arabian Gulf area. This epidemic is tending to hit more people at a younger age. Al-Rubeaan reported in their large cohort study that age ≥ 45 years is a risk factor for developing diabetic foot ulcers in a Saudi population [27]. Univariate analysis has shown a number of factors that predict amputation, namely older age and higher WBC counts. These findings have been reported in national Saudi studies as well as in international studies with large cohorts [27, 28]. An older age is likely to be associated with a poorer outcome probably because of a slower immune response to infection and the presence of other comorbidities that delay healing such as an impaired vascular blood flow. On the other hand, a longer duration of diabetes is likely to be associated with more diabetic complications such as micro and macrovascular complications, which are likely to play crucial roles in the skin breach and the perpetuation of the ulcer. Although the finding of an association between low HbA1c and amputation in the current study seems unusual, considering the mean age of the group as well as their diabetics status, it is likely that such patients suffer renal impairment, which is reflected in deceptively better glycaemic control. It is not surprising to find an association between increased total WBCs and an increased frequency of amputation, since the former is known to be associated with poorer glucose metabolism and infection. However, in our setting, it is obvious that the sample size lacks enough power to recognize increased TWBCs as a risk factor. In line with other studies, the current study found that an ischaemic ulcer is less likely to lead to an amputation than a neuropathic ulcer [27]. Likewise, the current study showed that a higher Wagner’s grade was associated with an increased incidence of amputation if compared to the lower grades, a finding that has been shown by different studies. Our findings were further supported by a group of Kenyan researchers in their cross sectional study among more than one thousand diabetics with diabetic foot ulcers [29].

Conclusion

The current study concludes that although a number of factors have been described to complicate diabetic ulcers by different researchers, none of those factors were identified in our study apart from older age and high WBC.

Limitations

We acknowledge that the sample size is rather small, as reflected by the wide confidence intervals. Moreover, despite the importance of vascular assessment, we were not able to include it in our analysis.
  26 in total

1.  Diabetic heel ulcer in the Sudan: determinants of outcome.

Authors:  Haseeb E Bakheit; Mohamed F Mohamed; Seif ElDin I Mahadi; Abu Bakr H Widatalla; Mohamed A Shawer; Amar H Khamis; Mohamed E Ahmed
Journal:  J Foot Ankle Surg       Date:  2011-11-10       Impact factor: 1.286

2.  Risk factors for lower extremity amputation in diabetic foot disease categorized by Wagner classification.

Authors:  Jui-Hung Sun; Jir-Shiong Tsai; Chung-Huei Huang; Chia-Hung Lin; Hui-Mei Yang; Yi-Sheng Chan; Sheng-Hwu Hsieh; Brend Ray-Sea Hsu; Yu-Yao Huang
Journal:  Diabetes Res Clin Pract       Date:  2011-11-23       Impact factor: 5.602

3.  Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia

Authors:  N Unwin
Journal:  Br J Surg       Date:  2000-03       Impact factor: 6.939

4.  Characteristics Predicting the Outcome in Individuals with Diabetic Foot Ulcerations.

Authors:  Lourdes Vella; Cynthia Formosa
Journal:  J Am Podiatr Med Assoc       Date:  2017-05

Review 5.  [Epidemiology of diabetic foot problems].

Authors:  J-L Richard; S Schuldiner
Journal:  Rev Med Interne       Date:  2008-09       Impact factor: 0.728

6.  Anemia in Patients With Diabetic Foot Ulcer: Prevalence, Clinical Characteristics, and Outcome.

Authors:  Fengning Chuan; Min Zhang; Yang Yao; Wenqing Tian; Xiaoqun He; Bo Zhou
Journal:  Int J Low Extrem Wounds       Date:  2016-07-20       Impact factor: 2.057

7.  The prevalence and incidence of diabetic foot ulcers among five countries in the Arab world: a systematic review.

Authors:  M Mairghani; K Elmusharaf; D Patton; J Burns; O Eltahir; G Jassim; Z Moore
Journal:  J Wound Care       Date:  2017-09-01       Impact factor: 2.072

8.  Limb amputation and limb deficiency: epidemiology and recent trends in the United States.

Authors:  Timothy R Dillingham; Liliana E Pezzin; Ellen J MacKenzie
Journal:  South Med J       Date:  2002-08       Impact factor: 0.954

9.  Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study.

Authors:  L Prompers; N Schaper; J Apelqvist; M Edmonds; E Jude; D Mauricio; L Uccioli; V Urbancic; K Bakker; P Holstein; A Jirkovska; A Piaggesi; G Ragnarson-Tennvall; H Reike; M Spraul; K Van Acker; J Van Baal; F Van Merode; I Ferreira; M Huijberts
Journal:  Diabetologia       Date:  2008-02-23       Impact factor: 10.122

10.  Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study.

Authors:  Leon Litwak; Su-Yen Goh; Zanariah Hussein; Rachid Malek; Vinay Prusty; Mohammad E Khamseh
Journal:  Diabetol Metab Syndr       Date:  2013-10-24       Impact factor: 3.320

View more
  10 in total

1.  Glycemic control and diabetic foot ulcer outcomes: A systematic review and meta-analysis of observational studies.

Authors:  Kyrstin L Lane; Mohammed S Abusamaan; Betiel Fesseha Voss; Emilia G Thurber; Noora Al-Hajri; Shraddha Gopakumar; Jimmy T Le; Sharoon Gill; Jaime Blanck; Laura Prichett; Caitlin W Hicks; Ronald L Sherman; Christopher J Abularrage; Nestoras N Mathioudakis
Journal:  J Diabetes Complications       Date:  2020-05-22       Impact factor: 2.852

2.  Impaired quality of life and diabetic foot disease in Saudi patients with type 2 diabetes: A cross-sectional analysis.

Authors:  Sana A AlSadrah
Journal:  SAGE Open Med       Date:  2019-02-21

3.  Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials.

Authors:  Rakesh Sharma; Suresh K Sharma; Shiv Kumar Mudgal; Prasuna Jelly; Kalpana Thakur
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

4.  Sex difference for the risk of amputation in diabetic patients: A systematic review and meta-analysis.

Authors:  Lei Fan; Xue-Jian Wu
Journal:  PLoS One       Date:  2021-03-11       Impact factor: 3.240

5.  Rates and risk factors for amputation in people with diabetes in Japan: a historical cohort study using a nationwide claims database.

Authors:  Masanori Kaneko; Kazuya Fujihara; Mayuko Yamada Harada; Taeko Osawa; Masahiko Yamamoto; Masaru Kitazawa; Yasuhiro Matsubayashi; Takaho Yamada; Hiroyasu Seida; Satoru Kodama; Hirohito Sone
Journal:  J Foot Ankle Res       Date:  2021-04-09       Impact factor: 2.303

6.  Pattern and type of amputation and mortality rate associated with diabetic foot in Jeddah, Saudi Arabia: A retrospective Cohort Study.

Authors:  Abdullah Abdulaziz Almohammadi; Maryam Mohammed Alnashri; Rawan Abdulrahman T Harun; Sarah Mohammed Alsamiri; Maram Taha Alkhatieb
Journal:  Ann Med Surg (Lond)       Date:  2021-12-08

7.  The Patterns of Acquired Upper and Lower Extremity Amputation at a Tertiary Centre in Saudi Arabia.

Authors:  Fayez M Alshehri; Salwa A Ahmed; Sami Ullah; Haitham Ghazal; Shah Nawaz; Ahmed S Alzahrani
Journal:  Cureus       Date:  2022-04-11

8.  A study of apolipoprotein A1(ApoA1) and interleukin-10(IL-10) in diabetes with foot ulcers.

Authors:  Rachita Nanda; Suprava Patel; Amritava Ghosh; K S Asha; Eli Mohapatra
Journal:  Biomedicine (Taipei)       Date:  2022-03-01

9.  Prevalence of foot ulcers in diabetic patients in Punjab, Pakistan.

Authors:  Sohail Akhtar; Mujahid Latif; Omer Shabbir Ahmed; Aqsa Sarwar; Ayisham Alina; Muhammad Imran Khan
Journal:  Front Public Health       Date:  2022-08-08

10.  Risk factors for lower extremity amputation in patients with diabetic foot ulcers: A meta-analysis.

Authors:  Chunmei Lin; Jinhao Liu; Hu Sun
Journal:  PLoS One       Date:  2020-09-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.